There is generally a moment in my office when it all clicks into focus for a patient receiving a new diagnosis of ...

In the UK, one in 10 women has Endometriosis. With March marking Endometriosis Awareness Month, Dr Bhavini Shah, a GP from ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The new pill is the first long-term daily pill licensed to treat the condition, and works by blocking specific hormones that ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo) is the first long-term daily ...

Endometriosis affects 1 in 10 women, yet diagnosis takes nearly a decade, leading to prolonged pain, infertility and organ ...

Endometriosis affects about 1 in 10 women. But women see seven physicians on average before they get diagnosed.

A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to ...

Endometriosis treatments range from drugs to surgery. It’s debated if surgery is better than drugs or the reverse.

The new tablet, known as Ryeqo or relugolix-estradiol-norethisterone, has been approved to treat women of reproductive age ...

Endometriosis and fibroids are two of the most common health issues affecting women often leading to severe pain heavy ...